Summary
This 8-K filing from Bristol-Myers Squibb Company (BMY) on October 13, 2005, primarily reports on key executive appointments and compensation. The most significant events include the appointment of Richard K. Willard as Senior Vice President and General Counsel, effective October 10, 2005, along with details of his compensation package which includes a substantial base salary, target bonus, and performance share units tied to company performance metrics. Additionally, the report announces the promotion of Joseph C. Caldarella to Vice President and Controller, effective the same date. David L. Zabor is transitioning to a new role within the company and is no longer serving as Controller. These changes in senior leadership positions are important for investors to note as they can signal shifts in strategy, operational focus, or governance.
Key Highlights
- 1Appointment of Richard K. Willard as Senior Vice President and General Counsel, effective October 10, 2005.
- 2Richard K. Willard's compensation package includes a $700,000 annual base salary and a target total cash compensation of $1,330,000.
- 3Mr. Willard received a grant of 19,300 performance share units with payouts contingent on continued service and company performance (EPS, sales, TSR).
- 4Promotion of Joseph C. Caldarella to Vice President and Controller, effective October 10, 2005.
- 5David L. Zabor has transitioned from his role as Controller to a new position within the company.
- 6The Compensation and Management Development Committee approved the compensation and performance metrics for Mr. Willard's award.
- 7The performance share unit payout for Mr. Willard is determined by specific company performance measures approved on March 1, 2005.